Overcoming Commercialization Challenges For Cell & Gene Therapies
The early promise offered by cell therapies and gene therapies is tempered by the challenges associated with developing, manufacturing, and delivering the drug product to patients.
This panel discussion highlights technical and regulatory hurdles associated with development and manufacturing steps, and strategies and solutions to facilitate development through commercialization.
Experts from contract development and manufacturing organizations, including Tom VanCott, Ph.D., Global Head of Product Development, Catalent Cell & Gene Therapy, discuss and debate the best approaches to successfully bring emerging therapies to patients.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.